CytoReason vs Embryonics
CytoReason vs Embryonics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and Embryonics on 45/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 45/100
- domain rating: 40/100 against 20/100
- headcount: 116 against 7
- headcount growth: +13.7% against -25.7%
- LinkedIn following: 12,830 against 2,042
Embryonics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CytoReason | Embryonics |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered platform enhancing IVF success rates by analyzing embryo development. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Medical Imaging, InVitro Fertilization (IVF), HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2016 | 2018 |
| Headquarters | Tel Aviv, Israel | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | CytoReason | Embryonics |
|---|---|---|
| Employees | 116 | 7 |
| Headcount growthLast 12 months | +13.7% | -25.7% |
| Total funding | $128M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 12,830 | 2,042 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | Embryonics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 45/100 |
| Traction | 60/100 | 9/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 30/100 | 33/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 20/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | Embryonics |
|---|---|---|
| CMS | Not detected | Wix |
| Frameworks | Not detected | Jquery |
| Analytics | Segment | Not detected |
CytoReason vs Embryonics: common questions
Which is better, CytoReason or Embryonics?
On our 0-100 score CytoReason rates higher (68/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CytoReason and Embryonics compare on the numbers?
CytoReason leads on our overall score (68/100 against 45/100), domain rating (40/100 against 20/100), headcount (116 against 7), headcount growth (+13.7% against -25.7%), LinkedIn following (12,830 against 2,042).
Read the full CytoReason review and pricing or the Embryonics review and pricing. You can also browse other CytoReason alternatives we track.